Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis

Tetrahydrocurcumin (THC), a major metabolite of curcumin (CUR), has been demonstrated to have potent anti-cancerogenic activity. The anti-carcinogenic effects of this compound is demonstrated by its ability to inhibit tumour initiation by azoxymethane (AOM).

The anti-inflammatory and anti-carcinogenic activities of CUR have been studied by research groups and the action mechanism of CUR is found to be complicated. Tetrahydrocurcumin, a partially reduced derivative of Curcumin found in turmeric, appears to be the major active metabolite formed when Curcumin is administered in mice.

Sabinsa Corporation may use your contact data to keep you informed of its products and services by email. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to dataprivacy@sabinsa.com. More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Policy.